Close
Biotechgate
| |

Home Page

Nuvectra® to Participate in Two Upcoming Investor Conferences
By: Nasdaq / GlobenewsWire - 12 Jun 2019Back to overview list

PLANO, Texas, June 12, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that members of management are scheduled to participate in two upcoming investor conferences in New York, NY.

          
    Event:    Raymond James 2019 Life Sciences and MedTech Conference
    Date:    Tuesday, June 18, 2019
    Time:    11:30 a.m. ET
    Location:    Lotte New York Palace Hotel
    Format:    Presentation & 1x1 Meetings
          
    Event:    JMP Securities Life Sciences Conference
    Date:    Wednesday, June 19, 2019
    Time:    2:00 p.m. ET
    Location:    The St. Regis New York
    Format:    Presentation & 1x1 Meetings
          

Webcasts of the Company’s presentations will be available by visiting the investor relations section of Nuvectra’s website at www.nuvectramed.com. Webcast replays of the presentations will be available for 90 days.

About Nuvectra Corporation

Nuvectra® is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder, and deep brain stimulation (DBS) for the treatment of Parkinson’s Disease. Visit the Nuvectra website at www.nuvectramed.com.

                
Company Contacts:              Investor Contacts:
Nuvectra Corporation              The Ruth Group
                
Jennifer Kosharek              Tram Bui
(214) 474-3107              (646) 536-7035
jkosharek@nuvectramed.com              investors@nuvectramed.com

Related companies:Nuvectra Corporation
Copyright 2019 Nasdaq / GlobenewsWire Back to overview list
to the top ↑